A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer

by Cai, Y., Li, M., Wu, J., Zhao, G.
Published 2021

ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer

by Kretowski, A., Markiewicz, A., Muchlinska, A., Nagel, A., Niemira, M., Popeda, M., Sadej, R., Skokowski, J., Szade, J., Zaczek, A.J, Zielinski, J.
Published 2022

Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from...

by Dunbar, M., Geyer, C.E, Golshan, M., Harkness, C., Huober, J., Loibl, S., Lorenzo, J.P, Maag, D., McIntyre, K., Metzger, O., O'Shaughnessy, J., Rastogi, P., Rugo, H.S, Sikov, W.M, Sohn, J.H, Symmans, W.F, Untch, M., Wolmark, N., Wright, G.S, Yardley, D., Young, R.
Published 2022

The Effect of Intratumoral Interrelation among FOXP3+ Regulatory T Cells on Treatment Response and Survival in Triple-Negative Breast Cancer

by Goda, N., Nagamine, I., Nakashima, C., Otagaki, S.
Published 2022

MiR-150-5p Overexpression in Triple-Negative Breast Cancer Contributes to the In Vitro Aggressiveness of This Breast Cancer Subtype

by Aneja, R., Cavalli, I.J, Cavalli, L.R, Fonseca, A.S, Kallakury, B., Ribeiro, E.M.S.F, Rodriguez, Y., Souza, E.N, Sugita, B.M
Published 2022

Boesenbergia stenophylla-Derived Stenophyllol B Exerts Antiproliferative and Oxidative Stress Responses in Triple-Negative Breast Cancer Cells with Few Side Effects in Normal Cells

by Chang, H.-W, Choo, Y.-M, Hou, M.-F, Kao, C.-L, Lee, M.-Y, Primus, P.S, Shiau, J.-P, Tang, J.-Y
Published 2023